Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Sell

C

BiomX Inc. (PHGE)

Biological Products, (no Disgnostic Substances)

https://www.biomx.com

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis.

22 EINSTEIN ST., 4TH FLOOR
NESS ZIONA, L3

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/13/2019

Market Cap

11,559,940

Shares Outstanding

45,980,000

Weighted SO

45,979,930

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

KRBP --.--%

ZVSA --.--%

YS --.--%

NAVB --.--%

IMMX --.--%

CNSP --.--%

EFTR --.--%

SONN --.--%

Beta

1.3130

Last Div

0.0000

Range

0.154-0.855

Chg

0.0029

Avg Vol

263362

Mkt Cap

11559940

Exch

AMEX

Country

IL

Phone

972 7 2394 2377

DCF Diff

0.2926

DCF

-0.1298

Div Yield

0.0000

P/S

-5.0679

EV Multiple

-1.3024

P/FV

421.5293

Div Yield %

0.0000

P/E

-491.3273

PEG

-19.6531

Payout

0.0000

Current Ratio

0.0000

Quick Ratio

0.0000

Cash Ratio

0.0000

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1791.8182

CCC

-1791.8182

Gross Margin

1.2893

Op Margin

7.4156

Pretax Margin

12.1306

Net Margin

10.3152

Eff Tax Rate

0.1494

ROA

0.0000

ROE

-1.5294

ROCE

2.3155

NI/EBT

0.8503

EBT/EBIT

1.6358

EBIT/Rev

7.4156

Debt Ratio

0.0000

D/E

0.3608

LT Debt/Cap

0.2439

Total Debt/Cap

0.2652

Int Coverage

-8.6433

CF/Debt

-2.7887

Equity Multi

0.0000

Rec Turnover

0.0000

Pay Turnover

0.2037

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.0004

FCF/Share

-0.0004

Cash/Share

0.0000

OCF/Sales

12.0986

FCF/OCF

1.0008

CF Coverage

-2.7887

ST Coverage

-26.3582

CapEx Coverage

-1199.8696

Div&CapEx Cov

-1199.8696

P/BV

421.5293

P/B

421.5293

P/S

-5.0679

P/E

-491.3273

P/FCF

-0.4185

P/OCF

-418.9021

P/CF

-418.9021

PEG

-19.6531

P/S

-5.0679

EV Multiple

-1.3024

P/FV

421.5293

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 29, 06:30 BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis GlobeNewswire Inc. Nov 14, 06:30 BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update

Revenue Product Segmentation